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Chicken infectious anemia (CIA) has recently emerged as an important disease problem in some of 
Africa’s major poultry-producing countries. Economic losses due to this disease arises from poor 
growth, increased mortality, carcass condemnations and the cost of antibiotics used to control 
secondary bacterial infections. Thus, it constitutes a significant threat to the continent’s food security 
efforts. Published studies were reviewed to obtain data on techniques used for serological detection as 
well as biological and molecular diagnosis of CIA virus (CIAV) in Africa. In the African countries where 
CIAV has been reported, diagnosis involved the use of serological, biological and nucleic acid-based 
detection techniques. While serological investigations detected CIAV antibodies in chickens in South 
Africa, Egypt and Nigeria, monoclonal antibody reactivity showed that CIAV isolates from Nigeria were 
antigenically related to the reference Cuxhaven-1 virus. The polymerase chain reaction detected CIAV 
DNA in tissues, blood and sera of infected chickens while restriction endonuclease analysis indicated 
the circulation of a mixed population of CIAV strains among chickens in Africa. Analysis of sequenced 
isolates revealed that the amino acid composition of African CIAV strains was highly conserved. The 
implications of these findings for the epidemiology and control of CIA in African poultry are discussed.  
 





Livestock, including poultry, are the major capital asset 
and income generation source of smallholder farmers in 
many developing countries where they often contribute 
up to 50% of agricultural gross domestic product and 
provide between 20-60% of household income on small-
holder farms (ILRI, 2009). In particular, poultry are a good 
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Abbreviations: CIA, Chicken infectious anemia; CIAV, chicken 
infectious anemia virus; IBD, infectious bursal  disease; IBDV 
(bold), infectious bursal disease virus (unbold); SPF, specific-
pathogen-free; IIF, indirect immunofluorescence; VNT, virus 
neutralization test; ELISA, enzyme-linked immunosorbent 
assay; MBE, monoclonal blocking enzyme-linked  
immunosorbent assay; CPE, cytopathic effect; AGPT, agar gel 
precipitin test; PCR, polymerase chain reaction; DNA, 
deoxyribonucleic acid; MAbs, monoclonal antibodies; RE, 
restriction endonuclease.  
African countries. However, there are some factors which 
constitute major constraints to the development and 
improvement of the poultry industry in Africa. These 
include lack of selection, low genetic potential, poor 
nutrition, low productivity of some indigenous stock and 
high incidence of infectious diseases, all of which 
constitute a great setback to the continent’s food security 
efforts. Some of these infectious diseases include 
Newcastle disease, Marek’s disease, infectious bursal 
disease (IBD), fowl pox, infectious bronchitis, fowl 
cholera, fowl typhoid, avian leukosis, mycoplasmosis and 
avian influenza (Hamid and Sharma, 1990; Adene, 1997; 
Joannis et al., 2006).  
In the last three decades, chicken infectious anemia (CIA) 
has emerged as a new economically important disease 
that causes severe anemia and hemorrhages in young 
chickens. This disease is associated with immunosup-
pression due to subclinical illness, leading to enhanced 
infections by secondary viral, bacterial or fungal agents. 
Immunosuppression  resulting   from   CIA   virus   (CIAV)  




infection could also lead to vaccination failures. 
This disease is caused by CIAV which is a small, non-
enveloped, icosahedral virus measuring 25 nm in 
diameter with a negative-sense, single-stranded circular 
DNA genome of about 2.3 kilobase pairs (Gelderblom et 
al., 1989). It has been classified as the only member of 
the genus Gyrovirus in the family Circoviridae (Pringle, 
1999). The CIAV genome encodes proteins of about 50, 
30 and 16 kDa, which have been designated VP1, VP2 
and VP3, respectively. VP1 is the viral capsid protein while 
VP3 or apoptin causes apoptosis in chicken thymocytes 
and chicken lymphoblastoid cells. It has been proposed 
that VP2 acts as a scaffold protein, ensuring that VP1 
folds in the proper way (Schat, 2003). 
Diagnosis of CIAV infections can be made by detecting 
infectious virus, virus antigen, virus DNA, or virus-specific 
antibodies (McNulty, 1998). The purpose of this article is 
to define the current state of knowledge concerning the 
serological, biological and molecular diagnosis of CIA in 
Africa and also emphasize the need to eradicate this 
disease from the continent.  
 
 
HISTORY AND ECONOMIC IMPACT OF CHICKEN 
INFECTIOUS ANEMIA  
 
Chicken infectious anemia was first recognized as a new 
disease in young chickens caused by a novel virus agent. 
The virus was isolated unexpectedly from commercial 
chickens during investigation of a Marek’s disease vaccine 
accident caused by reticuloendotheliosis virus in Japan in 
1974 (Yuasa et al., 1979). The newly described condition 
was associated with increased mortality in very young 
chickens that was characterized by severe anemia, 
lymphoid depletion, yellow to white bone marrow, atrophy 
of the thymus and bursa of Fabricius and hemorrhage 
(Yuasa et al., 1979).  
Infection with CIAV poses a serious economic threat 
especially to the broiler industry and the producers of 
specific-pathogen-free (SPF) eggs. Economic losses due 
to CIAV infections arise from poor growth, increased 
mortality and the cost of antibiotics used to control 
secondary bacterial infections (McNulty, 1991). It has 
been reported that net income per 1000 birds, feed 
conversion ratio and average weight per bird were lower 
in flocks with antibodies to CIAV compared to those 
without antibodies (McNulty et al., 1991). In addition, 
McIlroy et al. (1992) reported a loss of net income of 
about 18.5% due to decreased weight at processing and 





A definitive diagnosis of CIA can be made by virus 
isolation, demonstration of virus antigen in impression 





serum antibodies to the virus and detection of CIAV 
nucleic acid in tissues from diseased birds and infected 
Marek’s disease virus-transformed chicken lymphoblastoid 





Serological testing of poultry flocks for CIAV infections is 
necessary to determine whether breeder flocks have 
seroconverted during the rearing period, whether 
vaccination is warranted and to monitor its outcome and 
lastly, to monitor the CIAV status of SPF flocks especially 
those used to provide eggs for vaccine production (Todd 
et al., 2001). CIAV antibodies are produced post-infection 
and post-vaccination and can be detected by indirect 
immunofluorescence (IIF) and immunoperoxidase tests 
and virus neutralization test (VNT). However, these tests 
have been superseded by the enzyme-linked 
immunosorbent assay (ELISA) (McNulty, 1998). While 
several ELISAs have been developed for CIAV antibody 
detection (Todd et al., 1990; Pallister et al., 1994; Todd et 
al., 1999), commercial ELISAs for serodiagnosis of CIAV 
are now also available.  
In Egypt, serological investigations showed that 
commercial chickens were greatly exposed to CIAV (Zaki 
and El-Sanousi, 1994; Amin et al., 1998). Using 
commercial ELISA kits, Owoade et al. (2004) found that 
55% of 20 chicken flocks and 86% of seven farms tested 
in southwestern Nigeria were positive for CIAV 
antibodies. Subsequently, Emikpe et al. (2005) presented 
the first evidence that indigenous chickens in Africa were 
susceptible to CIA when they reported a CIAV sero-
prevalence of 88.9% among apparently healthy Nigerian 
indigenous chickens in four communities in southwestern 
Nigeria. Recently, Oluwayelu et al. (2009) reported the 
development and use of a monoclonal blocking ELISA 
(MBE) for the serodiagnosis of CIA in Nigeria. 
Performance evaluation of the MBE using Nigerian and 
Northern Ireland commercial chicken sera revealed 99.3 
and 86.1% concordance respectively, between the MBE 
and the commercial IDEXX CIAV ELISA (IDE) (IDEXX, 
Maine, USA) and between the MBE and the indirect 
ELISA. Compared with the IDE and the indirect ELISA, 
there were substantial reductions in reagent costs, time 
and labor input with the MBE, thus making it a rapid and 
more economical option for surveillance and 
serodiagnosis of CIAV infections. The MBE will therefore 
be applicable in most of Africa’s developing economies 
where commercial ELISA kits are expensive and largely 
unavailable for routine diagnostic use. In an earlier study 
which evaluated the performance of the IIF for CIAV 
serodiagnosis (Oluwayelu et al., 2007), it was observed 
that similar to the MBE, the IIF is cheap in terms of 
equipment cost, time and labor input and can also be 










CIAV has been isolated from chickens in Japan, West 
Germany, the United Kingdom, Sweden, the Netherlands, 
France, Australia, the United States, Brazil, New 
Zealand, Argentina, China and Chile. Apart from one-
day-old chicks and chicken embryos, several cell lines 
including the MDCC-MSB1, MDCC-JP2, LSCC-1104B1 
and MDCC-CU147 have been used for isolating the virus 
(Schat, 2003). However, the MDCC-MSB1 or MDCC-
CU147 cell lines are preferred for virus isolation and 
propagation (Calnek et al., 2000). Cultures showing 
cytopathic effect (CPE), which is characterized by cell 
death, enlarged swollen cells, alkaline medium and 
inability to subculture after 1 - 6 (but sometimes up to 10) 
subcultures, are suggestive of CIAV infection (McNulty, 
1991).  
In Africa, CIAV was first isolated from broiler chickens 
in South Africa (Wicht and Maharaj, 1993) and later from 
broilers in Egypt (Aly, 2001). This was followed by the 
report of Hussein et al. (2002) who isolated the virus by 
inoculating 1-day-old SPF chicks with tissue suspensions 
from clinically and subclinically infected broiler breeders 
in Egypt. Recently, Oluwayelu et al. (2005) isolated CIAV 
from birds that died in disease outbreaks tentatively 
diagnosed as IBD based on positive results obtained with 
the agar gel precipitin test (AGPT). Following inoculation 
of MDCC-MSB1 cells with tissue suspensions positive for 
CIAV DNA by the polymerase chain reaction (PCR), four 
samples caused CPE after 11 - 14 passages. Presence 
of CIAV antigens in these samples was demonstrated by 
IIF using monoclonal antibodies (MAbs) 3B1 and 2A9 
(McNulty et al., 1990b). Virus isolation was unsuccessful 
in two other PCR-positive samples.  
 
 
Antigenic relationship of CIAV isolates 
 
CIAV isolates from different geographical areas of the 
world are antigenically indistinguishable by serum neutra-
lization tests (Yuasa and Imai, 1986). However, it is 
possible to differentiate them using immunofluorescent 
staining patterns with MAbs (McNulty et al., 1990b), 
restriction endonuclease (RE) analysis (Todd et al., 1992) 
and sequence comparisons (Islam et al., 2002). 
Specifically, MAb reactivity has revealed antigenic 
differences between the reference Cuxhaven-1 (Cux-1) 
virus and Japanese, UK, USA and Australian isolates 
(McNulty et al., 1990b; Connor et al., 1991). 
A limiting-dilution method with a panel of four MAbs 
prepared against the CIAV isolate was used in reactions 
with antigens of the four Nigerian and Cux-1 isolates by 
the IIF. The Nigerian isolates were found to be anti-
genically closely related to each other and to the Cux-1 
virus as MAbs 3B1, 2A9 and 1H1 were  reactive  with  the  




Nigerian isolates at dilutions similar to those reactive with 





Virus isolation in SPF chicks or MDCC-MSB1 cells is 
laborious and time-consuming as it requires many 
passages. However, the development of the PCR has 
made rapid detection of the virus possible. In addition, 
RE mapping of the virus genome permits characterization 
of the virus. 
 
 
Polymerase chain reaction (PCR) 
 
The PCR has proven to be specific and more sensitive 
than cell culture isolation of CIAV and facilitates 
sequence and RE analysis. It is the assay of choice for 
detecting CIAV DNA in infected cell cultures, chicken 
tissues, archived formalin-fixed paraffin-embedded tissues, 
or vaccines (Schat, 2003). A real-time PCR assay has 
also been developed for the quantitation of CIAV DNA 
and RNA (Markowski-Grimsrud et al., 2002).  
Using the PCR for molecular diagnosis of CIAV in 
Egypt, Hussein et al. (2002) detected a 418 base pair 
(bp) CIAV-specific band in blood and tissue samples from 
infected broiler breeder chicks. In Nigeria, Oluwayelu et 
al. (2005) used a sensitive PCR assay to confirm the 
presence of CIAV DNA in tissues of necropsied birds. 
Agarose gel electrophoresis revealed a 733 bp DNA 
fragment which was the same size as that produced 
using DNA specific to the Cux-1 CIAV. Furthermore, 
Ducatez et al. (2006) used the PCR (nested and semi-
nested formats) in establishing the molecular epide-
miology of CIAV in Nigeria. In a recent report (Oluwayelu, 
2009), CIAV DNA was demonstrated by PCR in archived 
bursa of Fabricius samples from outbreaks that had been 
tentatively diagnosed as IBD based on pathological 
findings and positive AGPT results. This study which is 
the first PCR detection of CIAV DNA in archived chicken 
tissues, also established the fact that CIAV has been 
circulating, undiagnosed, in the Nigerian poultry 
population since, at least, 1999.  
 
 
Restriction endonuclease (RE) analysis  
 
Todd et al. (1992) reported the use of RE analysis of 
amplified DNA fragments to differentiate CIAV isolates 
from diverse geographical locations. They showed that 
the 14 CIAV isolates studied can be assigned to seven 
distinct groups. Recently, PCR-restriction endonuclease 
analysis was employed to characterize six CIAVs from 
Nigerian commercial chickens (Oluwayelu et al., 2005). 
Using CfoI enzyme, three different RE patterns were 
obtained.     Three    samples    yielded    fragments   with 




estimated sizes of 288, 244, 150 and 51 bp as expected 
for the reference Cux-1 virus while two had fragments 
with estimated sizes of 340, 190, 160 and 45 bp. The last 
sample had a unique profile also resembling that of Cux-
1 but with additional fragments of approximately 340 and 
190 bp in submolar amounts. These findings indicate the 
circulation of more than one CIAV strain among the 
Nigerian commercial chicken population and infer that the 
sample that had two additional fragments (340 and 190 
bp) in submolar quantities contained a mixed population 
of CIAV strains. Since CIAV has not been routinely 
diagnosed in indigenous chickens, Oluwayelu and Todd 
(2008) used the PCR-RE analysis also for the detection 
and characterization of CIAV in Nigerian indigenous 
chickens as a step to elucidating their role in the 
epidemiology of CIAV infections. Digestion of DNA from 
the sera of these indigenous chickens with CfoI yielded a 
RE pattern similar to that of the Cux-1 but also with the 
same additional fragments (340 and 190 bp). This 
suggests that the indigenous chickens also contained a 
mixed population of CIAV strains.  
 
 
Sequence and phylogenetic analysis 
 
DNA sequence determination can be used to differentiate 
CIAV isolates. Since the genome sequence of CIAV was 
first published (Noteborn et al., 1991), several low- and 
high-passage isolates have been sequenced (Meehan et 
al., 1992; Renshaw et al., 1996; Islam et al., 2002). The 
extent of genetic diversity in these sequences determines 
the biological behavior of individual virus strains. In a 
molecular epidemiological study of CIAV in Nigeria, 
Ducatez et al. (2006) reported that the nucleotide and 
amino acid diversities of the VP1 sequences of 30 
Nigerian CIAVs were 4.4 and 2.5%, respectively. When 
the nucleotide sequences of the VP1, VP2 and VP3 
genes of these CIAV strains were compared, they found 
that VP1 was more diverse than the other two CIAV 
genes. This is consistent with the findings of van Santen 
et al. (2001) and Islam et al. (2002) who reported that 
VP1 was more variable at the amino acid level than VP2 
and VP3.  
Furthermore, in a recent study to determine the extent 
of genetic diversity between CIAVs circulating in 
commercial and indigenous chickens, Oluwayelu et al. 
(2008) reported the partial sequencing of the VP1 gene of 
three Nigerian commercial chicken CIAV strains 
(designated NGR-1,  NGR-4 and NGR-5) and the cloning 
and sequencing of CIAV DNA extracted from the sera of 
Nigerian indigenous chickens. NGR-1, and NGR-4 and 
NGR-5 were more variable (maximum diversity of 6%) 
than the six indigenous chicken cloned strains   (designa-
ted NGR/Cl-1, NGR/Cl-2, NGR/Cl-5, NGR/Cl-7, NGR/Cl-8 
and NGR/Cl-9) that had a maximum diversity of 4%. The 
sequences of two indigenous chicken strains, NGR/Cl-8 
and NGR/Cl-9, were almost identical and evolutionarily 





NGR-4 and NGR-5, respectively (Oluwayelu et al., 2008). 
A 98% nucleotide identity existed between NGR-1 and a 
Malaysian strain (SMSC-1) and between NGR-4 and the 
Bangladeshi virus (BD-3). Similar to the findings of van 
Santen et al. (2001) and Ducatez et al. (2006) on the 
existence of CIAV mixed infections or quasispecies and 
the earlier report of Oluwayelu and Todd (2008) that 
indigenous chickens probably harbor a mixed population 
of CIAV strains, co-infection of at least two CIAV strains 





In selecting a test for serodiagnosis of CIA, especially 
when large number of sera are involved, consideration 
should be given to cost and time factors. Serological 
evidence of CIAV presence in South Africa, Egypt and 
Nigeria was provided using commercial ELISA kits, which 
are not easily available and affordable for routine 
diagnosis. On the other hand, for serodiagnosis of CIA, 
the MBE has been shown to be comparable in 
performance to the IIF (Oluwayelu et al., 2007) and to 
have advantages in terms of cost, time and labor input 
over the IDE and the indirect ELISA (Oluwayelu et al., 
2009). Thus, large scale seroepidemiological investigations 
of CIAV should be carried out to evaluate the full potential 
of the MBE and to determine the distribution of CIAV in 
other African countries. Since vaccination against CIAV is 
currently not practiced in Egypt and Nigeria, the high CIA 
seroprevalence obtained in apparently healthy 
commercial chickens in these countries is an indication of 
subclinical exposure to the virus. In view of the fact that 
CIAV causes immunosuppression, the detection of its 
presence in commercial chickens suggests that inade-
quate response to vaccinations with other agents seen in 
these chickens may be due to CIAV infections. In 
addition, since vaccination and other disease preventive 
measures are not practiced in indigenous chickens in 
Africa, the detection of CIAV DNA and antibodies in the 
sera of these free-roaming chickens (Emikpe et al., 2005; 
Oluwayelu et al., 2009) indicates natural exposure to the 
virus and implicates them as a potential source of the 
infection to commercial chickens. Indigenous chickens 
should therefore be taken into consideration in future 
reviews of national vaccination and disease elimination 
policies in all African countries.  
Results of virus isolation studies (Oluwayelu et al., 
2005) showed that, unlike other isolates elsewhere 
(McNulty et al., 1989, 1990a), the four Nigerian CIAV 
isolates that replicated in cells seem to be slow-growing 
strains of the virus, as it took a minimum of 11 passages 
before they could produce CPE. Also, the finding that two 
samples did not grow in MDCC-MSB1 cells is consistent 
with previous reports that not all field strains of CIAV 
replicate in these cells (Yuasa et al., 1983; Soine et al., 
1994; Islam et al., 2002). It is possible that the CIAV 





other cell lines that have been observed to be permissive 
for some CIAV strains (Calnek et al., 2000). Moreover, it 
has been suggested that certain amino acid exchanges in 
the VP1 hypervariable region (amino acid 139-151) 
probably contribute to differences in efficiency of CIAV 
replication in vitro (Renshaw et al., 1996). In addition, van 
Santen et al. (2001) suggested an association between 
the occurrence of glutamine on position 22 of the VP1 
protein of field isolates of CIAV with poor replication 
kinetics and slow replication in cell culture. It is possible 
that the two Nigerian CIAVs that did not replicate in cell 
culture contained these amino acid polymorphisms.   
The IIF performed with four MAbs prepared against the 
Cux-1 isolate revealed the existence of antigenic similarity 
between the Cux-1 and Nigerian isolates (Oluwayelu et 
al., 2005). This agrees with reports that all CIAVs are 
antigenically related (Yuasa and Imai, 1986; McNulty et 
al., 1990a) and indicates that the Nigerian isolates belong 
to the same serotype as those from other geographical 
areas of the world. However, an antigenically different 
isolate (CIAV-7), which is regarded as a putative second 
serotype, has been reported in the USA (Spackman et 
al., 2002a, b). This report underscores the possibility that, 
although only one serotype of CIAV has been identified 
so far, additional serotypes may emerge in the future. 
This could have important consequences for vaccine 
efficacy and serodiagnosis. In Africa, efforts should be 
made to isolate and serotype CIAV from chickens in 
those countries where no information on CIA is currently 
available in order to determine their antigenic relatedness 
to existing isolates of the virus.  
The detection of CIAV DNA in chicken tissues, blood 
and sera in Egypt and Nigeria (Hussein et al., 2002; 
Ducatez et al., 2006; Oluwayelu et al., 2008) using PCR 
underscores the increasing importance of this diagnostic 
technique as a rapid, highly sensitive and specific method 
of diagnosing infectious agents. The high sensitivity of 
the PCR in detecting CIAV DNA suggests that it will be 
valuable for detecting extraneous CIAV in poultry 
vaccines being marketed in the continent. Moreover, the 
PCR detection of CIAV DNA in archived chicken tissues 
that were positive for IBDV antigen (Oluwayelu, 2009) 
suggests co-infection of IBD and CIA. This is consistent 
with reports of synergistic interaction between IBDV and 
CIAV (Imai et al., 1999) and indicates that CIA should be 
considered as a differential diagnosis in cases that 
present with ‘IBD-like’ clinical signs and pathology.  
The finding of Ducatez et al. (2006) and Oluwayelu et 
al. (2008) that the nucleotide and amino acid sequences 
of Nigerian CIAV strains are conserved is consistent with 
the report that CIAV isolates show extremely limited 
genetic variability worldwide (van Santen et al., 2001). 
However, biological differences exemplified by ability to 
replicate in cell culture exist among Nigerian CIAV strains 
despite low genetic variability of isolates. The report of a 
high level of genetic relatedness between Nigerian 
indigenous   and   commercial    chicken    CIAV    strains  




(Oluwayelu et al., 2008) is an indication that CIAV 
infection is not restricted to the farm premises. The virus 
may have spread from the farm to the indigenous 
chickens, or vice versa. The practice of culling and selling 
spent layers, some of which may be harboring the virus 
and ultimately end up as backyard chickens, may 
contribute to dissemination of this virus in the field. 
Furthermore, the finding of high level (98%) of nucleotide 
identity between NGR-1 and Malaysian SMSC-1 and 
between NGR-4 and BD-3 show that NGR-1 and SMSC-
1 on one hand and NGR-4 and BD-3 on the other, share 
common evolutionary origins. Since vaccination against 
CIAV is not done in Nigeria at present, it is likely that 
these two CIAV strains were introduced into the Nigerian 
poultry population through importation of infected poultry, 
poultry vaccines or other biologicals. It is advocated that 
importation of day-old chicks by poultry farmers should 
be discouraged by governments across Africa since such 
chicks are a potential source of introduction of the virus. 
In addition, poultry biologicals especially vaccines 
imported into the continent should be regularly screened 
for contamination with CIAV.  
The detection of six distinct CIAV variants in Nigerian 
indigenous chickens using molecular cloning and 
sequence analysis (Oluwayelu et al., 2008) confirmed the 
findings of RE analysis which suggested that both 
commercial and indigenous chickens contain mixed 
populations of CIAV (Oluwayelu et al., 2005; Oluwayelu 
and Todd, 2008). Other workers (van Santen et al., 2001; 
Ducatez et al., 2006) made similar findings of mixed 
infections or quasispecies among CIAV strains. Van 
Santen et al. (2001) suggested that this phenomenon 
could be due to a recombination event. Recently, He et 
al. (2007) provided evidence that homologous recom-
bination occurred between two CIAV strains and resulted 
in a novel CIAV genotype. It has also been reported that 
virulent variants of some other viruses have been 
generated by homologous recombination (Worobey et al., 
1999; Anderson et al., 2000). Since the virulence of CIAV 
is mainly determined by VP1 (Yamaguchi et al., 2001) 
and the recombination between CIAVs occurred in VP1, 
there is a need to further investigate the existence of 
homologous recombinants among African CIAV strains 
and subsequently evaluate the effect of homologous 
recombination on the virulence of these African strains.  
Furthermore, genetic typing which has been used as a 
tool for tracing the spread of CIAV (Natesan et al., 2006; 
Simionatto et al., 2006), can be used by epidemiologists 
to trace the origin of CIAV in commercial and indigenous 
poultry populations in Africa and to monitor its spread. 
The above findings, coupled with the fact that African 
indigenous chickens comprise a mixture of different 
breeds, suggest that these chickens can provide a rich 
milieu for the generation of novel genotypes of CIAV that 
may alter the epidemiologic picture of this virus in future. 
It can be concluded that lower productivity and poor 
performance generally associated  with  African  indigenous  




chickens, among other factors, are also related to CIAV 
infections.  
Control measures for CIA should include vaccination 
and good poultry health and management practices. 
CIAV immunization of breeder flocks during rearing, 
which has been used successfully elsewhere (Vielitz et 
al., 1987; Steenhuisen et al., 1994), is therefore 
advocated to ensure more protective levels of passive 
immunity for the progeny chicks during the first weeks of 
life. This will minimize vertical transmission of the virus. 
However, consideration should be given to the nature 
and immunopathogenesis of CIAV infection in relation to 
other agents before the introduction of CIAV vaccination 
programme. In particular, since co-infection with IBDV 
enhances the pathogenicity of CIAV, control of IBD 
should be an integral part of any measures to control 
CIAV. The presence of high level of genetic similarity 
between indigenous and commercial chicken CIAV 
strains in Nigeria underlines the need for improved 
hygiene and biosecurity on poultry farms across Africa to 
prevent cross-contamination between flocks and intro-
duction of virus from indigenous to commercial chickens, 
or vice versa. Moreover, contacts between overlapping 
susceptible and infected flocks should be avoided. In 
addition, periodic decontamination and proper timing of 
flocks should be practiced.  
There are still many gaps in our knowledge of the 
pathology, pathogenesis and epidemiology of CIAV in 
Africa, especially in indigenous chickens. With the 
availability of reagents and modern technologies such as 
CIAV-specific monoclonal antibodies, immunohistochemical 
methods, DNA probes and PCR-based molecular detection 
techniques, it should be possible in the near future to 
answer questions about CIAV persistence, the patho-
genesis of subclinical infections, the role of CIAV in 
immunosuppression and its interaction with other viruses 
and infectious agents in African poultry. In addition, the 
establishment of an African poultry disease database 
which will contain basic information about African isolates 
of poultry disease agents and their sequences is 
recommended. This will be an invaluable resource that 
can be accessed for the development of more sensitive, 
rapid and cheaper diagnostic tests and for future vaccine 
development purposes. It is further advocated that 
studies should be conducted to evaluate the economic 
losses caused by CIA in Africa, especially in indigenous 
chickens with the aim of determining the impact on the 
income generation capacity of the average   African 
household which depends on income from small-holder 
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